Latest Regulatory News

Mayne Pharma shareholders have overwhelmingly approved the scheme of arrangement for Cosette Pharmaceuticals to acquire the company at $7.40 per share, despite ongoing legal challenges and regulatory approvals still pending.

Bioxyne Limited, through its subsidiary Breathe Life Sciences, has secured a significant supply agreement to enter Germany’s burgeoning medical cannabis market, promising at least A$5.6 million in revenue for FY2026.

Alligator Energy advances regulatory approvals and construction preparations for its Samphire Uranium Project’s Field Recovery Trial, a critical step toward commercial production.

Estrella Resources has ramped up its manganese exploration at the Ira Miri Project in Timor-Leste with a more powerful diamond drill rig and a fresh supergene manganese outcrop discovery, setting the stage for an extensive drilling program.

Platinum Asset Management and L1 Capital have advanced their merger talks, completing due diligence and proposing a revised ownership structure favoring L1 Capital shareholders. The deal also outlines a nuanced performance fee arrangement tied to L1’s Long Short funds.

Bastion Minerals has launched a non-renounceable rights issue to raise up to $677,721, offering eligible shareholders in Australia and New Zealand the chance to increase their holdings at a minimal price. The capital will support ongoing project evaluations and working capital needs.

Bastion Minerals Limited has announced a non-renounceable pro-rata rights issue to raise approximately $677,721 at a 50% discount to the last trading price. The funds will support ongoing project evaluation and working capital needs.

Lakes Blue Energy NL has secured $6.5 million through a fully underwritten placement to fund drilling at its Wombat Gas Field in Victoria, aiming to address looming gas supply shortages on Australia's east coast.

INOVIQ Limited has announced a breakthrough in its cancer treatment program, with its CAR-exosome therapy killing 88% of triple negative breast and lung cancer cells in laboratory studies. This innovation could pave the way for faster, safer, and more accessible cancer therapies.

Bioxyne Limited's subsidiary Breathe Life Sciences has achieved key GMP certifications across multiple international markets, paving the way for expanded operations in Europe, the UK, Canada, and Singapore. The company signals strong growth prospects for FY2026, with formal guidance expected in August.

FireFly Metals has filed a final prospectus for a C$25.7 million bought deal offering as part of a broader A$71 million equity raise to advance its high-grade copper-gold projects in Canada. The capital raise includes institutional placements, a charity flow-through placement, and a share purchase plan.

Hazer Group Limited has opened a $2 million underwritten Share Purchase Plan, offering eligible shareholders in Australia and New Zealand the chance to buy shares at the same price as a recent institutional placement. The funds will support the commercialisation of its methane reactor technology and synthetic graphite development.